Ticker Scorecard - PRPH Basics Company: ProPhase Labs, Inc. IPO Date: May 1, 1994 Sector: Healthcare Industry: Pharma Market Cap: $12.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.49% Avg Daily Range (30 D): $0.05 | 9.24% Avg Daily Range (90 D): $0.05 | 5.92% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): 13.16M Avg Daily Volume (90 D): 4.6M Trade Size Avg Trade Size (Sh.): 398 Avg Trade Size (Sh.) (30 D): 761 Avg Trade Size (Sh.) (90 D): 743 Institutional Trades Total Inst.Trades: 17 Avg Inst. Trade: $.97M Avg Inst. Trade (30 D): $4.5M Avg Inst. Trade (90 D): $4.5M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.36M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 127.12K     News Nov 8, 2024 @ 4:37 AM ProPhase Labs Announces Pricing of Public Offering... Source: N/A Aug 7, 2024 @ 1:01 PM Antibody Production Market to Surpass USD 36.49 Bi... Source: Sns Insider Jun 6, 2024 @ 12:00 PM Rare Stock Picks In May 2024 - From 29 Discerning ... Source: SA Rare Stock Picks Monthly May 9, 2024 @ 7:40 PM ProPhase Labs Announces Financial Results for the ... Source: ProPhase Labs, Inc. May 7, 2024 @ 12:10 PM Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Miss... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.53 $-.35 $-.33 Diluted EPS $-1.53 $-.35 $-.33 Revenue $ 12.75M $ 3.15M $ 2.47M Gross Profit $ -4.13M $ -.17M $ -.48M Net Income / Loss $ -27.76M $ -6.59M $ -6.15M Operating Income / Loss $ -35.41M $ -7.94M $ -7.83M Cost of Revenue $ 16.88M $ 3.31M $ 2.95M Net Cash Flow $ .39M $ -1.27M $ .63M PE Ratio